---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-24-017141"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:35:57.846570+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro enters ATM offering for up to $6.5M in common stock

## Summary
- Entered ATM Sales Agreement with Ascendiant Capital Markets for up to $6.5M of common stock.
- Shares sold from time to time at market prices; agent receives customary commission.
- Prospectus supplement filed Oct 3, 2024; relies on shelf registration statement 333-273610.
- ATM offering provides additional capital but dilutes existing shareholders.

## SEC filing metadata
- accession: 0001214659-24-017141
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/0001214659-24-017141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/g1032408k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-24-017141
- JSON: https://secwatch.observer/filing/0001214659-24-017141.json
- Plain text: https://secwatch.observer/filing/0001214659-24-017141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.